UPB

Upstream Bio Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 9/10
  • Momentum↓ 1/10
Upstream Bio sales and earnings growth
UPB Growth
Great
  • Revenue Y/Y↑ 26.82%
  • EPS Y/Y↑ 146.10%
  • FCF Y/Y↓ -118.86%
Upstream Bio gross and profit margin trends
UPB Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -4386.40%
  • ROIC↓ -40.80%
Upstream Bio net debt vs free cash flow
UPB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Upstream Bio stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗